Strategy& Insider Podcast - Episode 43 with Dr. Kahina Lang
Dr. Kahina Lang, head of NextGen Drug Delivery at Merk Group, describes building an agile, startup-style international research unit of 40+ experts across three continents focused on organ- and cell-specific mRNA delivery using nanoparticle carriers. The team aims to direct mRNA therapies precisely to target tissues, leveraging corporate manufacturing, regulatory and IP resources while retaining startup speed and autonomy. Lang connects her leadership and resilience to a background in elite gymnastics and multicultural experience, and she outlines operational challenges in scaling delivery platforms and integrating with legacy R&D processes. The conversation highlights both technical progress in lipid nanoparticle engineering and strategic choices to balance innovation with quality and manufacturability.
Fear Contagion
The video explains a new study on fear contagion – the rapid spread of fear among animals – and its neurochemical basis. Researchers asked whether oxytocin, a hormone linked to love and empathy in mammals, also governs this phenomenon in...
Rice that Beats the Heat
The video reports the discovery of a heat‑responsive gene, QT12, on rice chromosome 12 that determines how the grain copes with rising nighttime temperatures. Researchers screened more than 500 rice varieties in heat‑prone regions, cross‑breeding the top performers until they...
Knowing How Injection Volumes Impact Delivery Options
The panel discussed how the volume that can be self‑administered determines whether a therapy is delivered via a pre‑filled syringe (PFS), an autoinjector, or an infusion system. Speakers emphasized that the deciding factor is the drug’s pharmacokinetic profile. Antibodies that merely...
Relying On Human Factors Clinical Data For Regulatory Approvals
The discussion centered on the growing regulatory focus on human‑factors engineering in medical‑device submissions, especially within the FDA’s Center for Devices and Radiological Health. Participants noted that the agency’s human‑factors experts have become more visible over the past decade, and...
Confirming Study Approaches For Clinical Bridging
During the Drug Delivery Leader Live event, Chief Editor Tom von Gunden prompted panelist Beate Bittner to discuss patient‑centric considerations as drug and delivery products transition to clinical trials. Bittner emphasized that leveraging established platforms and data from previous studies...
Determining Dosing For IV Or Subcutaneous Delivery
In a Drug Delivery Leader Live session, panelist Beate Bittner discussed early‑stage formulation decisions from a patient dosing perspective, comparing intravenous (IV) and subcutaneous (SC) routes. She highlighted how drug stability, bioavailability, administration frequency, and patient convenience shape the choice...
Phase 2 in Sight as Reinvention Reaps Rewards
Perseron Therapeutics announced a strategic shift from rare‑disease research to cancer immunotherapy, centering on its lead asset HMBBD2. The drug activates the newly identified Vista pathway, a departure from the PD‑1 axis that dominates current checkpoint inhibitors. The company reported that...
Oral GLP-1 Breakthrough - Arecor CEO on Improving Bioavailability for Obesity Treatment
The video centers on Arecor’s effort to develop an oral GLP‑1 formulation that overcomes the chronic low‑bioavailability problem plaguing peptide therapeutics, especially for obesity treatment. The CEO highlights that while more than a hundred peptide candidates are in development for...
Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer
Jared Bauer, co‑founder and CEO of Seek Labs, detailed his experience turning around biotech firms and launching an integrated AI‑diagnostic and CRISPR‑therapeutics platform for infectious diseases. He highlighted a proof‑of‑concept study against African Swine Fever that markedly reduced viremia in...
NEJM This Week — February 12, 2026
NEJM This Week (Feb 12 2026) highlights several pivotal studies, including promising phase‑III results for novel IgA nephropathy therapies and updated antithrombotic regimens after coronary stenting. Researchers identified the specific antigen driving rare vaccine‑associated clotting syndromes, while a case report underscored the...
Genflow Biosciences, KEFI Gold and Copper, Valereum, Seeing Machines, Arecor Therapeutics, S&U
Proactive’s weekly roundup highlighted six small‑cap stocks delivering notable milestones, ranging from clinical breakthroughs to financing deals. The segment covered Genflow Biosciences’ promising aged‑dog trial, KEFI Gold & Copper’s $340 million project financing in Ethiopia, Valereum’s partnership with RWA.io, Seeing Machines’...
Lupin Q3 Profit Jumps 37%! Is $1 Billion US Sales Next? | Margin Outlook & GLP-1 Big Bet | ET...
Lupin reported a 37% jump in Q3 profit, reaching ₹1,175.5 crore, and reaffirmed its aim to cross $1 billion in U.S. sales this fiscal year. The company also lifted its full‑year EBITDA margin outlook to 27‑28%, up from the prior 29‑30% nine‑month...
LIVE Replay: Where Science Meets Strategy: Inside Life Sciences Consulting
Life sciences consulting sits at the crossroads of scientific innovation, commercial strategy, and healthcare delivery, as highlighted in a 2026 panel featuring leaders from Guidehouse, Clarkston Consulting, ClearView Healthcare Partners, and Roland Berger. The discussion identified key trends such as...
Tiny Robot Fish Could Swim Through the Body Powered by Ultrasound
The video introduces acoustic robotics, where tiny polymer devices are powered solely by ultrasound‑induced bubble dynamics, eliminating wires, batteries, or magnets and opening the door to fully wireless medical microrobots. A thin polymer sheet is laser‑molded with thousands of sub‑millimetre cavities...
IROS 2025 Keynotes - Medical Robots: Li Zhang
Li Zhang’s IROS 2025 keynote highlighted the rapid evolution of miniature biomedical robots, emphasizing magnetic actuation, bio‑hybrid materials, and modular architectures for safe, targeted therapy. He traced the concept back to Richard Feynman’s swallowable‑surgery vision and described how his team fabricates...
IPO Anniversary BioVersys at SIX
BioVersys commemorated its first anniversary on the SIX Swiss Exchange, reaffirming its mission to combat drug‑resistant bacterial infections. The company highlighted how antibiotic resistance now jeopardizes advances such as oncology therapies, underscoring the urgency of new antibiotics. The listing has amplified...
The RNA Multiverse with Julius Lucks
The Nanoccape episode spotlights Professor Julius Lucks, a chemical‑engineer turned synthetic biologist, who explores RNA’s “multiverse” – its ability to fold, wiggle, and act as a molecular computer. Leveraging nanotechnology principles, Lucks and his team engineered RNA sensors that emit...
What if Plastic Didn’t Last Forever? #TEDTalks
The talk introduces a new class of biodegradable bioplastic created by a startup that harnesses bacteria to eat organic waste. Founded in 2018, the company transforms by‑products such as spent brewery yeast into a polymer that behaves like conventional petroleum‑based...
HEALEY ALS Platform Trial Webinar: January 22, 2026 | Research Access
The webinar hosted by the Healey Center at Mass General introduced the ongoing ALS platform trial, highlighted patient‑navigation resources, and announced the upcoming launch of a new drug regimen (NUZ001) in 2026. Organizers explained how the platform trial uses a shared...
Patient Updates From the 2025 ASH Annual Meeting: Leukemia (Part 3)
At the 2025 ASH meeting presenters highlighted two key leukemia developments: a randomized phase II comparison showed lower‑intensity azacitidine plus venetoclax outperformed intensive 7+3 chemotherapy for event‑free survival and remission depth in a selected AML population, and more patients on...
Payments, Pain, and Pragmatic AI in Clinical Trials - Life Sciences Today Podcast Episode 47
Ledger Run CEO John Chanichi describes his journey from engineering and consulting to building a business platform that streamlines clinical-trial operations, with a particular focus on participant payments, study logistics and data workflows. Ledger Run targets biopharma sponsors and CROs...
Weighing Molecules with Light | The Royal Society
Professor Philip Kukura’s Royal Society lecture explored how modern light‑based methods, especially mass spectrometry, let scientists weigh individual molecules— from tiny explosives to massive therapeutic viruses. He began by tracing the historical need for standardized mass, from barley‑based pounds to...
Intellectual Property Issues Between Vaxgen and the New Social Venture
The video examines the intellectual‑property landscape surrounding a new social‑venture partnership between Vaxgen and its licensing partner Janentech. The core agreement grants a not‑for‑profit foundation royalty‑free rights to develop and distribute a vaccine in low‑income regions, while reserving commercial rights...
Meet 2025 President’s Innovation Challenge Finalist: TerraFlow
TerraFlow, a finalist in the 2025 President’s Innovation Challenge, was introduced by founder Dan Freeman, a Harvard‑Med PhD student whose personal loss of his mother to cancer in December 2023 fuels the company’s urgency to speed life‑saving trials. Freeman explains that...
Aminoglycoside and Its Medical Applications (5 Minutes)
The video provides a concise overview of aminoglycoside antibiotics, detailing their mechanism of action, clinical indications, dosing strategies, toxicity profile, and stewardship considerations for modern practice. Dr. Biotech Whisperer explains that these agents bind the bacterial 16S rRNA, freeze the initiation...
Understanding Teicoplanin and Its Medical Applications (4 Minutes)
Understanding teicoplanin’s role in modern antimicrobial therapy is the focus of this four‑minute briefing. The lecture outlines the drug’s unique lipid‑tail structure that anchors it to the bacterial cell wall, amplifying local concentration and delivering rapid, concentration‑dependent killing with a...
Micro Diagnostics and How It Works (4 Minutes)
Micro Diagnostics Unpacked outlines a new paradigm where precision biomarker analysis, point‑of‑care integration, and AI‑driven interpretation converge into a seamless workflow. The video demonstrates how connected devices feed real‑time readouts into dashboards that clinicians can consult during routine care, cutting...
Gene Guns Let You Shoot DNA Into Things
Gene guns, also called biolistic devices, fire nanometer‑scale gold particles coated with DNA directly into living cells. The method bypasses traditional vectors such as Agrobacterium, offering a physical route to introduce genetic material into a wide range of organisms, especially...
Sickle Cell: Natural Selection in Humans | HHMI BioInteractive Video
The HHMI BioInteractive video uses Morgan Grace’s personal story to illustrate why a seemingly harmful genetic mutation—sickle cell disease—remains common in certain human populations. It explains the molecular basis of the disorder, how a single‑base change in the hemoglobin gene...
Drug Discovery Made Simple (12 Minutes)
The video offers a concise roadmap of modern drug discovery, tracing the journey from target identification through pre‑clinical work to clinical trials. It emphasizes the multidisciplinary nature of the field—biology, chemistry, pharmacology, and computation—and highlights how recent technologies such as...
Google’s MedGemma 1.5 & MedASR: Open AI for Medical Imaging and Dictation
Google unveiled two new open‑source AI models aimed at accelerating medical imaging analysis and clinical documentation, expanding its MedGemma family with version 1.5 and launching MedASR for speech‑to‑text conversion. MedGemma 1.5 is a 4‑billion‑parameter multimodal model trained on the MedMA dataset....
Understanding Doxycycline and Its Medical Applications (5 Minutes)
The video provides a concise clinical primer on doxycycline, detailing its mechanism—binding the 30S ribosomal subunit to block tRNA entry—and highlighting its role as a versatile oral agent in both community and travel medicine. It emphasizes doxycycline’s broad‑spectrum activity against gram‑negative,...
Decoding Genomes Faster and More Accurately (5 Minutes)
The video provides a concise overview of next‑generation sequencing (NGS) and its rapid adoption in diagnostics and research. It contrasts classic Sanger sequencing—single‑fragment, high‑cost reads—with modern NGS that processes millions of fragments in parallel, delivering lower per‑base costs, higher throughput,...
Protein Structure Analysis Made Simple (4 Minutes)
Protein structure analysis is undergoing a rapid transformation as experimental advances such as cryo‑EM and synchrotron X‑ray combine with AI‑driven prediction tools. The talk outlines how the energy‑funnel model explains protein folding speed and underpins modern algorithms, while highlighting the...
Understanding Plant Root Stress Biology (5 Minutes)
The video introduces root stress biology, describing how roots detect drought, salinity, temperature shifts, and nutrient deficits, then coordinate whole‑plant responses.\n\nIt explains rapid signaling via calcium and reactive‑oxygen species waves transmitted through the xylem, DNA‑damage response involving ATM/ATR kinases and...
Web Tools for Bioinformatics Made Simple (4 Minutes)
The video introduces a suite of modern web‑based tools that simplify bioinformatics analysis, from data preprocessing to advanced genomic workflows, by leveraging browser‑native interfaces and cloud resources. It emphasizes how these platforms make reproducible science accessible to researchers without complex...
Working with Self-Check Models
In this tutorial, educator Emit walks viewers through the self‑check functionality of Model Builder, a web‑based platform that lets students construct causal, conceptual, or stock‑and‑flow models. The feature works like a jigsaw puzzle: a pre‑designed model is disassembled into component...
Comparing Model Types
In this instructional video, Casey, an educator who leverages the BioInteractive Model Builder, walks viewers through the three distinct model types the platform can generate—conceptual, causal, and stock‑and‑flow—and explains when each is most appropriate for higher‑education biology courses. The tutorial defines...
